Our Pricing

Mounjaro Injection Side Effects: Is It Safe for You?

Understanding mounjaro injection side effects UK is essential before starting treatment. Mounjaro (tirzepatide) is a licensed weight loss medication in the UK, and while clinical trials demonstrate significant efficacy, knowing what to expect helps you manage your treatment safely and confidently.

Common Mounjaro Side Effects: What to Expect

The most frequently reported mounjaro injection side effects UK patients experience are gastrointestinal in nature. In the SURMOUNT-1 trial, nausea affected 29-33% of participants, whilst diarrhoea occurred in 21-23%, and vomiting in 10-13% [1]. These side effects are typically mild to moderate and diminish significantly after the first 4-8 weeks as your body adjusts to the medication.

Other common side effects include decreased appetite (which contributes to weight loss), constipation (affecting approximately 17% of patients), abdominal discomfort, and injection site reactions such as redness or mild swelling [1]. Most patients find these manageable with simple dietary adjustments and proper injection technique.

It's important to note that side effect frequency is dose-dependent. Starting at the lowest 2.5mg dose and gradually escalating every four weeks — as prescribed by your UK clinician — allows your body to adapt and significantly reduces the severity of gastrointestinal symptoms [2].

Managing Nausea and Gastrointestinal Side Effects

Nausea is the most commonly reported mounjaro side effect, but several evidence-based strategies can help minimise discomfort. Eating smaller, more frequent meals throughout the day rather than three large meals reduces stomach distension and helps manage nausea. Avoiding high-fat, greasy, or heavily spiced foods during the first few weeks of treatment is particularly beneficial, as tirzepatide slows gastric emptying [3].

Staying well-hydrated is crucial, especially if you experience vomiting or diarrhoea. Sipping water throughout the day and choosing bland, easily digestible foods like toast, rice, bananas, and plain chicken can ease gastrointestinal symptoms. If nausea persists or becomes severe, your prescriber may recommend adjusting your dose escalation schedule or prescribing anti-nausea medication.

When Gastrointestinal Symptoms Require Medical Attention

Whilst mild nausea and diarrhoea are expected, certain symptoms warrant immediate medical review. Contact your GP or NHS 111 if you experience persistent vomiting that prevents you from keeping down fluids for more than 24 hours, severe abdominal pain that doesn't resolve, signs of dehydration (dark urine, dizziness, extreme thirst), or blood in your stool or vomit. These may indicate more serious complications requiring clinical assessment.

Serious but Rare Mounjaro Side Effects

Although uncommon, Mounjaro carries a small risk of serious adverse events that require awareness. Pancreatitis (inflammation of the pancreas) occurred in less than 0.2% of clinical trial participants but requires immediate medical attention if you develop severe, persistent abdominal pain radiating to your back, accompanied by nausea and vomiting [1][4].

Thyroid C-cell tumours were observed in rodent studies, leading to a boxed warning in the prescribing information. However, it's unclear whether this risk applies to humans. Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [4].

Gallbladder problems, including gallstones and cholecystitis, have been reported in patients taking GLP-1 receptor agonists. Rapid weight loss itself increases gallstone risk, making it difficult to isolate medication-specific effects. If you experience severe upper abdominal pain, particularly after eating, fever, or jaundice, seek medical attention promptly [3].

Is Mounjaro Safe? Understanding the Clinical Evidence

Mounjaro's safety profile has been extensively evaluated across multiple large-scale clinical trials involving over 6,000 participants. The SURMOUNT programme demonstrated that tirzepatide is generally well-tolerated, with the majority of adverse events being mild to moderate gastrointestinal symptoms that decreased over time [1][2].

The MHRA licensed Mounjaro for weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity, following rigorous safety and efficacy review. In clinical trials, serious adverse events occurred at similar rates between tirzepatide and placebo groups, suggesting the medication's safety when used under appropriate medical supervision [2].

However, Mounjaro isn't suitable for everyone. It's contraindicated in pregnancy, for patients with a history of severe gastrointestinal disease, those with personal or family history of medullary thyroid carcinoma, and individuals with Multiple Endocrine Neoplasia syndrome type 2. Your UK prescriber will assess your complete medical history during consultation to determine whether Mounjaro is safe and appropriate for you.

Long-Term Safety Considerations

Whilst clinical trials have followed participants for up to 72 weeks, Mounjaro is a relatively new medication, and long-term safety data beyond two years remains limited. Ongoing post-marketing surveillance continues to monitor for rare or delayed adverse effects. Your prescriber will schedule regular follow-up appointments to monitor your response, adjust dosing, and assess for any emerging safety concerns throughout your treatment journey.

Mounjaro Injection Side Effects vs Other Weight Loss Treatments

Comparing mounjaro injection side effects UK data with alternative treatments helps contextualise its safety profile. Wegovy (semaglutide), another GLP-1 receptor agonist, shares a similar side effect profile with comparable rates of nausea (44% in STEP-1 trial), diarrhoea, and vomiting [5]. However, tirzepatide's dual GIP/GLP-1 mechanism may produce slightly different gastrointestinal tolerability patterns in some patients.

Saxenda (liraglutide), a daily injectable GLP-1 agonist, reports nausea in approximately 39% of patients, though the daily dosing schedule may lead to more persistent low-grade symptoms compared to weekly injections [3]. Orlistat, a non-injectable alternative available from Cured Pharmacy from £135.00, causes different side effects entirely — primarily gastrointestinal issues related to fat malabsorption rather than appetite suppression.

Injectable treatments like Mounjaro and Wegovy generally produce more significant weight loss than oral medications, but this comes with the trade-off of injection-related side effects and the need for proper injection technique. Your UK prescriber will discuss which treatment option best balances efficacy, safety, and your personal preferences during your clinical assessment.

Starting Mounjaro Safely at Cured Pharmacy

At Cured Pharmacy, all Mounjaro prescriptions begin with a comprehensive online clinical assessment conducted by UK-registered prescribers. This consultation evaluates your medical history, current medications, contraindications, and suitability for tirzepatide treatment — ensuring you receive safe, personalised care before your first injection.

Mounjaro is available from £135.00 at Cured Pharmacy, with transparent upfront pricing displayed before your consultation. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees dispensing to ensure you receive genuine UK-licensed medication with complete patient information leaflets and injection guidance. All treatments are delivered in 100% discreet packaging with next-day delivery options available.

Your prescriber will start you on the lowest 2.5mg maintenance dose for the first four weeks, gradually escalating to minimise side effects whilst optimising weight loss results. You'll receive detailed injection instructions, side effect management guidance, and access to our clinical team throughout your treatment. Subject to prescriber approval, you can begin your Mounjaro journey with confidence, knowing you're supported by experienced UK healthcare professionals.

Ongoing Clinical Support and Monitoring

Weight loss treatment requires ongoing clinical oversight. Our team provides regular follow-up consultations to monitor your progress, assess side effects, adjust dosing as needed, and ensure Mounjaro remains safe and effective for you. If you experience concerning symptoms between consultations, our pharmacists are available via phone at (+44) 116 4646009 during business hours to provide guidance and triage urgent concerns appropriately.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Garvey, W. T., Frias, J. P., Jastreboff, A. M., le Roux, C. W., Sattar, N., Aizenberg, D., ... & Bunck, M. C. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X
3. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102
4. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics (SmPC). Retrieved from https://www.medicines.org.uk/emc/product/14395/smpc
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and its use must be supervised by an appropriately qualified healthcare professional.